A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin ≥ 13.2 g/dl
Article first published online: 16 MAY 2007
RCOG 2007 BJOG An International Journal of Obstetrics and Gynaecology
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 114, Issue 6, pages 684–688, June 2007
How to Cite
Ziaei, S., Norrozi, M., Faghihzadeh, S. and Jafarbegloo, E. (2007), A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin ≥ 13.2 g/dl. BJOG: An International Journal of Obstetrics & Gynaecology, 114: 684–688. doi: 10.1111/j.1471-0528.2007.01325.x
- Issue published online: 16 MAY 2007
- Article first published online: 16 MAY 2007
- Accepted 31 January 2007.
- Iron supplementation;
- nonanaemic women;
- pregnancy outcome
Objective To study the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin (Hb) ≥13.2 g/dl.
Design A randomised, double-blind, placebo-controlled trial.
Setting Routine health services.
Population Seven hundred and twenty-seven pregnant women with Hb ≥13.2 g/dl in the early stage of the second trimester.
Methods Each woman took one tablet of 50 mg of ferrous sulphate daily in the case group (n = 370) or placebo in the control group (n = 357) throughout pregnancy.
Main outcome measures Pregnancy outcome.
Results While there were no significant differences in demographic and obstetric characteristics between the two groups before any intervention, small-for-gestational-age birth rate and the number of women with hypertension disorder increased significantly in the case group in comparison with the control group (57 [15.7%] versus 36 [10.3%], P = 0.035, 10 [2.7%] versus 3 [8%], P = 0.05, respectively).
Conclusions Our finding proves that routine iron supplementation in nonanaemic women is not rational and may be harmful.